US 12,322,505 B2
Method and system for updating a medical device
Saeed Nekoomaram, San Mateo, CA (US); and Nathan C. Crouther, San Francisco, CA (US)
Assigned to ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed by ABBOTT DIABETES CARE INC., Alameda, CA (US)
Filed on Oct. 19, 2023, as Appl. No. 18/381,778.
Application 18/381,778 is a continuation of application No. 17/991,297, filed on Nov. 21, 2022, granted, now 11,854,693.
Application 17/991,297 is a continuation of application No. 17/720,082, filed on Apr. 13, 2022, abandoned.
Application 17/720,082 is a continuation of application No. 17/503,199, filed on Oct. 15, 2021, granted, now 11,309,078, issued on Apr. 19, 2022.
Application 17/503,199 is a continuation of application No. 15/588,587, filed on May 5, 2017, granted, now 11,152,112, issued on Oct. 19, 2019.
Application 15/588,587 is a continuation of application No. 14/804,244, filed on Jul. 20, 2015, granted, now 9,940,436, issued on Apr. 10, 2018.
Application 14/804,244 is a continuation of application No. 14/040,601, filed on Sep. 27, 2013, abandoned.
Application 14/040,601 is a continuation of application No. 12/794,721, filed on Jun. 4, 2010, granted, now 8,595,607, issued on Nov. 26, 2013.
Claims priority of provisional application 61/184,234, filed on Jun. 4, 2009.
Prior Publication US 2024/0312613 A1, Sep. 19, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 40/40 (2018.01); G06F 8/61 (2018.01); G06F 8/65 (2018.01); G06F 8/654 (2018.01); G06F 8/71 (2018.01); G06F 11/10 (2006.01); G06F 11/14 (2006.01); G08B 21/18 (2006.01); G08B 29/24 (2006.01); H03M 13/09 (2006.01); H04L 67/10 (2022.01); H04W 12/106 (2021.01); H04W 12/30 (2021.01)
CPC G16H 40/40 (2018.01) [G06F 8/61 (2013.01); G06F 8/65 (2013.01); G06F 8/654 (2018.02); G06F 8/71 (2013.01); G06F 11/1004 (2013.01); G06F 11/1433 (2013.01); G08B 21/182 (2013.01); G08B 29/24 (2013.01); H03M 13/09 (2013.01); H04L 67/10 (2013.01); H04W 12/106 (2021.01); H04W 12/35 (2021.01)] 18 Claims
OG exemplary drawing
 
1. A system comprising:
(1) an on body device configured to be positioned on a body of a user, the on body device comprising:
a transcutaneous glucose sensor, wherein a portion of the transcutaneous glucose sensor is configured to be positioned in the body of the user and continuously sense an in vivo glucose level of the user; and
a transmitter unit coupled with the transcutaneous glucose sensor and positioned on the body of the user, wherein the transmitter unit is configured to wirelessly transmit data to a first receiver device according to a Bluetooth communication protocol, wherein the first receiver device comprises a smart phone, and
wherein the transcutaneous glucose sensor and the transmitter unit are integrated in a single housing of the on body device; and
(2) a remote server comprising:
communication circuitry configured to establish communication with a plurality of receiver devices including the first receiver device and a secondary receiver device, wherein the communication circuitry is further configured to receive from the first receiver device: (a) a first sensor data based on the in vivo glucose level of the user sensed by the transcutaneous glucose sensor of the on body device; and (b) a set of configurable alert settings initially set to a first configuration by the user on the first receiver device, and
one or more processors of the remote server coupled with a memory of the remote server, the memory of the remote server storing a set of instructions that, when executed by the one or more processors of the remote server, cause the one or more processors of the remote server to:
transmit to the secondary receiver device a second sensor data, wherein the second sensor data is also based on the in vivo glucose level of the user sensed by the transcutaneous glucose sensor of the on body device, and
transmit to the secondary receiver device the set of configurable alert settings initially set to the first configuration by the user on the first receiver device,
wherein the second sensor data and the set of configurable alert settings are transmitted from the remote server to the secondary receiver device while the transcutaneous glucose sensor of the on body device is monitoring the in vivo glucose level of the user; and
(3) the secondary receiver device comprising one or more processors of the secondary receiver device coupled with a memory of the secondary receiver device, the memory of the secondary receiver device storing a set of instructions that, when executed by the one or more processors of the secondary receiver device, cause the one or more processors of the secondary receiver device to:
receive the second sensor data indicative of the in vivo glucose level of the user from the on body device, wherein the second sensor data is based on the in vivo glucose level of the user sensed by the transcutaneous glucose sensor of the on body device, and
receive the set of configurable alert settings initially set to the first configuration by the user, wherein the set of configurable alert settings are associated with the in vivo glucose level of the user.